Drug Shortage Report for COTAZYM

Last updated on 2024-07-09 History
Report ID 225096
Drug Identification Number 00263818
Brand name COTAZYM
Common or Proper name PANCRELIPASE CAPSULES
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) PROTEASE AMYLASE LIPASE
Strength(s) 35000UNIT 40000UNIT 10000UNIT
Dosage form(s) CAPSULE (IMMEDIATE RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-05-24
Actual start date 2024-05-22
Estimated end date 2024-11-29
Actual end date
Shortage status Actual shortage
Updated date 2024-07-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-07-09 English Compare
v11 2024-05-23 English Compare
v10 2024-05-22 French Compare
v9 2024-05-22 English Compare
v8 2024-05-17 French Compare
v7 2024-05-17 English Compare
v6 2024-05-10 French Compare
v5 2024-05-10 English Compare
v4 2024-05-01 French Compare
v3 2024-05-01 English Compare
v2 2024-04-12 French Compare
v1 2024-04-12 English Compare

Showing 1 to 12 of 12